NEVVI Medicare utilization intelligence

← back

HIRSCHFELD, AZRIELM.D. NPI 1043240336 Clinician

Hematology-Oncology · BROOKLYN, NY

Specialty Hematology-Oncology — from billed Medicare claims
Trained ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY — medical school, self-reported to CMS
In practice about 24 years since medical school (class of 2002, self-reported to CMS)
Location BROOKLYN, NY · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 29 codes billed · 89,514 disclosed services (CY2024 — most recent year in data)
Current groups
member of 2 groups; the volumes below are this clinician's personal volume and are not attributed to any single group

Group affiliation since 2019

20192026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2025-03

Year: 2024 · 2023 · 2022 locked column · 2021 locked column · 2020 locked column

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were premium in CY2024. Unlock to see the figure.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services locked column Beneficiary-episodes locked column Avg charge locked column Avg Medicare payment locked column
J9263 Injection, oxaliplatin, 0.5 mg premiumpremium premiumpremium
J2405 Injection, ondansetron hydrochloride, per 1 mg premiumpremium premiumpremium
J0461 Injection, atropine sulfate, 0.01 mg premiumpremium premiumpremium
J1100 Injection, dexamethasone sodium phosphate, 1 mg premiumpremium premiumpremium
J9206 Injection, irinotecan, 20 mg premiumpremium premiumpremium
J0640 Injection, leucovorin calcium, per 50 mg premiumpremium premiumpremium
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less premiumpremium premiumpremium
J9190 Injection, fluorouracil, 500 mg premiumpremium premiumpremium
J9201 Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg premiumpremium premiumpremium
J2916 Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg premiumpremium premiumpremium
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more premiumpremium premiumpremium
96413 Administration of chemotherapy into vein, 1 hour or less premiumpremium premiumpremium
96417 Administration of additional new drug or substance into vein, 1 hour or less premiumpremium premiumpremium
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more premiumpremium premiumpremium
96415 Administration of chemotherapy into vein, each additional hour premiumpremium premiumpremium
96361 Infusion into a vein for hydration, each additional hour premiumpremium premiumpremium
36415 Insertion of needle into vein for collection of blood sample premiumpremium premiumpremium
96375 Injection of additional new drug or substance into vein premiumpremium premiumpremium
96416 Administration of prolonged chemotherapy into vein premiumpremium premiumpremium
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count premiumpremium premiumpremium
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour premiumpremium premiumpremium
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) premiumpremium premiumpremium
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less premiumpremium premiumpremium
J7030 Infusion, normal saline solution , 1000 cc premiumpremium premiumpremium
J1200 Injection, diphenhydramine hcl, up to 50 mg premiumpremium premiumpremium
96372 Injection of drug or substance under skin or into muscle premiumpremium premiumpremium
99441 Telephone medical discussion with physician, 5-10 minutes premiumpremium premiumpremium
99442 Telephone medical discussion with physician, 11-20 minutes premiumpremium premiumpremium
96360 Infusion into a vein for hydration, 31-60 minutes premiumpremium premiumpremium

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.